Effects of two beta-adrenergic blocking agents, propranolol and INPEA, on lipid metabolism.
D000273:Adipose Tissue / Q000187:drug effects; D000315:Adrenalectomy; D000818:Animals; D004336:Drug Antagonism; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D009539:Nicotinic Acids; D013565:Sympatholytics; D010643:Phenoxybenzamine; D012110:Reserpine; D011433:Propranolol; D009638:Norepinephrine